FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767509615> ?p ?o ?g. }

• W2767509615 abstract "Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen and progesterone receptor expression (ESR and PGR, respectively) and an absence of human epithelial growth factor receptor (ERBB2) amplification. Approximately 15-20% of breast malignancies are TNBC. Patients with TNBC often have an unfavorable prognosis. In addition, TNBC represents an important clinical challenge since it does not respond to hormone therapy.In this work, we integrated high-throughput mRNA sequencing (RNA-Seq) data from normal and tumor tissues (obtained from The Cancer Genome Atlas, TCGA) and cell lines obtained through in-house sequencing or available from the Gene Expression Omnibus (GEO) to generate a unified list of differentially expressed (DE) genes. Methylome and proteomic data were integrated to our analysis to give further support to our findings. Genes that were overexpressed in TNBC were then curated to retain new potentially druggable targets based on in silico analysis. Knocking-down was used to assess gene importance for TNBC cell proliferation.Our pipeline analysis generated a list of 243 potential new targets for treating TNBC. We finally demonstrated that knock-down of Guanylate-Binding Protein 1 (GBP1 ), one of the candidate genes, selectively affected the growth of TNBC cell lines. Moreover, we showed that GBP1 expression was controlled by epidermal growth factor receptor (EGFR) in breast cancer cell lines.We propose that GBP1 is a new potential druggable therapeutic target for treating TNBC with enhanced EGFR expression." @default.
• W2767509615 created "2017-11-17" @default.
• W2767509615 creator A5035607526 @default.
• W2767509615 creator A5041118199 @default.
• W2767509615 creator A5045948252 @default.
• W2767509615 creator A5049662438 @default.
• W2767509615 creator A5054602755 @default.
• W2767509615 creator A5059640417 @default.
• W2767509615 creator A5061854308 @default.
• W2767509615 creator A5069135574 @default.
• W2767509615 creator A5086427255 @default.
• W2767509615 date "2017-11-07" @default.
• W2767509615 modified "2023-10-16" @default.
• W2767509615 title "Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer" @default.
• W2767509615 cites W1490161904 @default.
• W2767509615 cites W1505116396 @default.
• W2767509615 cites W1546952499 @default.
• W2767509615 cites W1554933414 @default.
• W2767509615 cites W1570051364 @default.
• W2767509615 cites W1617623684 @default.
• W2767509615 cites W1754973657 @default.
• W2767509615 cites W1761706969 @default.
• W2767509615 cites W1789924039 @default.
• W2767509615 cites W1861588860 @default.
• W2767509615 cites W1889405671 @default.
• W2767509615 cites W1933350662 @default.
• W2767509615 cites W1966327575 @default.
• W2767509615 cites W1969346276 @default.
• W2767509615 cites W1970871207 @default.
• W2767509615 cites W1975265345 @default.
• W2767509615 cites W1978067882 @default.
• W2767509615 cites W1979340580 @default.
• W2767509615 cites W1982861164 @default.
• W2767509615 cites W1983426138 @default.
• W2767509615 cites W1984236815 @default.
• W2767509615 cites W1988995745 @default.
• W2767509615 cites W1994363917 @default.
• W2767509615 cites W1999574084 @default.
• W2767509615 cites W1999670119 @default.
• W2767509615 cites W2002170815 @default.
• W2767509615 cites W2005895632 @default.
• W2767509615 cites W2006122819 @default.
• W2767509615 cites W2010522003 @default.
• W2767509615 cites W2019060272 @default.
• W2767509615 cites W2025531664 @default.
• W2767509615 cites W2032999587 @default.
• W2767509615 cites W2050345155 @default.
• W2767509615 cites W2053790759 @default.
• W2767509615 cites W2057635677 @default.
• W2767509615 cites W2061623393 @default.
• W2767509615 cites W2065828547 @default.
• W2767509615 cites W2067380588 @default.
• W2767509615 cites W2070480410 @default.
• W2767509615 cites W2077291760 @default.
• W2767509615 cites W2086601777 @default.
• W2767509615 cites W2089026309 @default.
• W2767509615 cites W2096781310 @default.
• W2767509615 cites W2100448568 @default.
• W2767509615 cites W2103017472 @default.
• W2767509615 cites W2106425267 @default.
• W2767509615 cites W2106660927 @default.
• W2767509615 cites W2107277218 @default.
• W2767509615 cites W2107564978 @default.
• W2767509615 cites W2112413148 @default.
• W2767509615 cites W2112720107 @default.
• W2767509615 cites W2116041602 @default.
• W2767509615 cites W2116634113 @default.
• W2767509615 cites W2118258530 @default.
• W2767509615 cites W2119883345 @default.
• W2767509615 cites W2120239384 @default.
• W2767509615 cites W2130919062 @default.
• W2767509615 cites W2131478115 @default.
• W2767509615 cites W2134133462 @default.
• W2767509615 cites W2134539328 @default.
• W2767509615 cites W2138929540 @default.
• W2767509615 cites W2140405480 @default.
• W2767509615 cites W2140593657 @default.
• W2767509615 cites W2140916263 @default.
• W2767509615 cites W2141458291 @default.
• W2767509615 cites W2146512944 @default.
• W2767509615 cites W2152239989 @default.
• W2767509615 cites W2156631105 @default.
• W2767509615 cites W2158804744 @default.
• W2767509615 cites W2160164696 @default.
• W2767509615 cites W2160734881 @default.
• W2767509615 cites W2162622637 @default.
• W2767509615 cites W2165446840 @default.
• W2767509615 cites W2166969772 @default.
• W2767509615 cites W2169121410 @default.
• W2767509615 cites W2169456326 @default.
• W2767509615 cites W2170318554 @default.
• W2767509615 cites W2170602872 @default.
• W2767509615 cites W2179438025 @default.
• W2767509615 cites W2192080449 @default.
• W2767509615 cites W2287472947 @default.
• W2767509615 cites W2288343188 @default.
• W2767509615 cites W2333905291 @default.
• W2767509615 cites W2395887422 @default.
• W2767509615 cites W2402636472 @default.
• W2767509615 cites W2509143635 @default.

• next